Northwest Medical Specialties Hematology/Oncology is a clinical research site located in Tacoma, Washington, United States 98405.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Northwest Medical Specialties Hematology/Oncology has participated in 2 clinical trials.
Therapeutic areas: PI3K Pathway Activated Tumors, Tumor Pathway Activations Inhibited by Dovitinib.
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Washington · View every site in Tacoma
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Northwest Medical Specialties Hematology/Oncology has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Northwest Medical Specialties Hematology/Oncology has 2 clinical trials on record. Their work covers PI3K Pathway Activated Tumors, Tumor Pathway Activations Inhibited by Dovitinib.
Northwest Medical Specialties Hematology/Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.